ID   A20.IIA-GFP
AC   CVCL_0J28
DR   Wikidata; Q54606432
RX   PubMed=21949734;
RX   PubMed=22400032;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0J27 ! A20.IIA
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 8
//
RX   PubMed=21949734; DOI=10.1371/journal.pone.0024622; PMCID=PMC3176763;
RA   Galand C., Donnou S., Crozet L., Brunet S., Touitou V., Ouakrim H.,
RA   Fridman W.H., Sautes-Fridman C., Fisson S.;
RT   "Th17 cells are involved in the local control of tumor progression in
RT   primary intraocular lymphoma.";
RL   PLoS ONE 6:e24622.1-e24622.7(2011).
//
RX   PubMed=22400032; DOI=10.1155/2012/701704; PMCID=PMC3287022;
RA   Donnou S., Galand C., Touitou V., Sautes-Fridman C., Fabry Z.,
RA   Fisson S.;
RT   "Murine models of B-cell lymphomas: promising tools for designing
RT   cancer therapies.";
RL   Adv. Hematol. 2012:701704.1-701704.13(2012).
//